BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tan Y, Wei QH, Chen LJ, Chan PC, Lai WS, He ML, Kung HF, Lee SS. Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China. PLoS One 2008;3:e3608. [PMID: 18974888 DOI: 10.1371/journal.pone.0003608] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Zhou B, Cai GFF, Lv HKK, Xu SFF, Wang ZTT, Jiang ZGG, Hu CGG, Chen YDD. Factors Correlating to the Development of Hepatitis C Virus Infection among Drug Users-Findings from a Systematic Review and Meta-Analysis. Int J Environ Res Public Health 2019;16:E2345. [PMID: 31269774 DOI: 10.3390/ijerph16132345] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
2 Zhang AM, Yang M, Gao L, Zhang M, Jiao L, Feng Y, Dong X, Xia X. The distinct epidemic characteristics of HCV co-infection among HIV-1-infected population caused by drug injection and sexual transmission in Yunnan, China. Epidemiol Infect 2019;147:e261. [PMID: 31475647 DOI: 10.1017/S0950268819001365] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Abler L, Henderson G, Wang X, Avery M, Zhang YX, Pan S. Affected by HIV stigma: interpreting results from a population survey of an urban center in Guangxi, China. AIDS Behav 2014;18 Suppl 2:S192-201. [PMID: 23892728 DOI: 10.1007/s10461-013-0556-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
4 Robaeys G, Bielen R, Azar DG, Razavi H, Nevens F. Global genotype distribution of hepatitis C viral infection among people who inject drugs. J Hepatol. 2016;65:1094-1103. [PMID: 27520879 DOI: 10.1016/j.jhep.2016.07.042] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 7.2] [Reference Citation Analysis]
5 Tian D, Li L, Liu Y, Li H, Xu X, Li J. Different HCV genotype distributions of HIV-infected individuals in Henan and Guangxi, China. PLoS One. 2012;7:e50343. [PMID: 23226265 DOI: 10.1371/journal.pone.0050343] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
6 Wong NS, Chan PC, Lee SS, Lee SL, Lee CK. A multilevel approach for assessing the variability of hepatitis C prevalence in injection drug users by their gathering places. Int J Infect Dis 2013;17:e193-8. [PMID: 23165126 DOI: 10.1016/j.ijid.2012.10.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
7 Lee YM, Lin HJ, Chen YJ, Lee CM, Wang SF, Chang KY, Chen TL, Liu HF, Chen YM. Molecular epidemiology of HCV genotypes among injection drug users in Taiwan: Full-length sequences of two new subtype 6w strains and a recombinant form_2b6w. J Med Virol. 2010;82:57-68. [PMID: 19950240 DOI: 10.1002/jmv.21658] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
8 Demetriou VL, van de Vijver DA, Hezka J, Kostrikis LG, Kostrikis LG. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus. J Med Virol. 2010;82:263-270. [PMID: 20029809 DOI: 10.1002/jmv.21690] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
9 Demetriou VL, Kostrikis LG. Molecular epidemiology of hepatitis C infection in Cyprus within the general population and high-risk cohorts. BMC Res Notes 2011;4:468. [PMID: 22040780 DOI: 10.1186/1756-0500-4-468] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
10 Culasso AC, Elizalde M, Campos RH, Barbini L. Molecular survey of hepatitis C virus in the touristic city of Mar del Plata, Argentina. PLoS One 2012;7:e44757. [PMID: 23028605 DOI: 10.1371/journal.pone.0044757] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
11 Yi L, Zhao J, Lu J, Chen Y, Chen L, Cheng J, Sun Y, Li Z, Men R, Yang L, Kung H, Yang Z, He ML. Gene expression profiling of CD4⁺ T cells in treatment-naive HIV, HCV mono- or co-infected Chinese. Virol J 2014;11:27. [PMID: 24520951 DOI: 10.1186/1743-422X-11-27] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
12 Li M, Li R, Shen Z, Li C, Liang N, Peng Z, Huang W, He C, Zhong F, Tang X, Lan G. Spatial distribution of HIV, HCV, and co-infections among drug users in the southwestern border areas of China (2004-2014): a cohort study of a national methadone maintenance treatment program. BMC Public Health 2017;17:759. [PMID: 28962612 DOI: 10.1186/s12889-017-4769-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
13 Zhou YB, Wang QX, Liang S, Gong YH, Yang MX, Nie SJ, Nan L, Yang AH, Liao Q, Yang Y, Song XX, Jiang QW. HIV-, HCV-, and co-infections and associated risk factors among drug users in southwestern China: a township-level ecological study incorporating spatial regression. PLoS One 2014;9:e93157. [PMID: 24687006 DOI: 10.1371/journal.pone.0093157] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
14 Wan Z, Chen Q, Chen X, Duo L, Li P, Zheng YT, Zhang C. HCV Diversity among Chinese and Burmese IDUs in Dehong, Yunnan, China. PLoS One 2016;11:e0163062. [PMID: 27657722 DOI: 10.1371/journal.pone.0163062] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
15 Huang K, Chen J, Xu R, Jiang X, Ma X, Jia M, Wang M, Huang J, Liao Q, Shan Z, Dailey C, Song X, Lu L, Li C, Rong X, Zhang M, Fu Y. Molecular evolution of hepatitis C virus in China: A nationwide study. Virology 2018;516:210-8. [PMID: 29407379 DOI: 10.1016/j.virol.2018.01.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
16 Golemba MD, Culasso AC, Villamil FG, Bare P, Gadano A, Ridruejo E, Martinez A, Di Lello FA, Campos RH. Hepatitis C virus diversification in Argentina: comparative analysis between the large city of Buenos Aires and the small rural town of O'Brien. PLoS One 2013;8:e84007. [PMID: 24386322 DOI: 10.1371/journal.pone.0084007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
17 Gu J, Bai Y, Lau JT, Hao Y, Cheng Y, Zhou R, Yu C. Social environmental factors and condom use among female injection drug users who are sex workers in China. AIDS Behav 2014;18 Suppl 2:S181-91. [PMID: 23443978 DOI: 10.1007/s10461-013-0434-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
18 Granados-García V, Flores YN, Díaz-Trejo LI, Méndez-Sánchez L, Liu S, Salinas-Escudero G, Toledano-Toledano F, Salmerón J. Estimating the prevalence of hepatitis C among intravenous drug users in upper middle income countries: A systematic review and meta-analysis. PLoS One 2019;14:e0212558. [PMID: 30807590 DOI: 10.1371/journal.pone.0212558] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
19 Tengan FM, Ibrahim KY, Dantas BP, Manchiero C, Magri MC, Bernardo WM. Seroprevalence of hepatitis C virus among people living with HIV/AIDS in Latin America and the Caribbean: a systematic review. BMC Infect Dis 2016;16:663. [PMID: 27829381 DOI: 10.1186/s12879-016-1988-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
20 Qi Y, Chen Q, Hao F, Wan Z, Guo H, Lu R, Mao L, Du H, Lu J, Zhang C. Subtype distribution of hepatitis C virus in Jiangsu, China. J Med Virol 2016;88:498-505. [PMID: 26288243 DOI: 10.1002/jmv.24356] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
21 Dong C, Huang ZJ, Martin MC, Huang J, Liu H, Deng B, Lai W, Liu L, Yang Y, Hu Y, Qin G, Zhang L, Song Z, Wei D, Nan L, Wang Q, Deng H, Zhang J, Wong FY, Yang W. The impact of social factors on human immunodeficiency virus and hepatitis C virus co-infection in a minority region of Si-chuan, the People's Republic of China: a population-based survey and testing study. PLoS One 2014;9:e101241. [PMID: 24988219 DOI: 10.1371/journal.pone.0101241] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
22 Zhao R, Peng J, Tang L, Huang H, Liu M, Kong W, Pang B. Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low. J Med Virol 2013;85:1712-23. [PMID: 23868809 DOI: 10.1002/jmv.23650] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
23 Zhang C, Wu N, Liu J, Ge Q, Huang Y, Ren Q, Feng Q, He G. HCV subtype characterization among injection drug users: implication for a crucial role of Zhenjiang in HCV transmission in China. PLoS One 2011;6:e16817. [PMID: 21304823 DOI: 10.1371/journal.pone.0016817] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
24 Du H, Qi Y, Hao F, Huang Y, Mao L, Ji S, Huang M, Qin C, Yan R, Zhu X. Complex patterns of HCV epidemic in Suzhou: evidence for dual infection and HCV recombination in East China. J Clin Virol. 2012;54:207-212. [PMID: 22595306 DOI: 10.1016/j.jcv.2012.04.017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
25 He L, Zhao J, Wang MH, Siu KK, Gan YX, Chen L, Zee BC, Yang L, Kung HF, Yang ZR, He ML. Interleukin-27 is differentially associated with HIV viral load and CD4+ T cell counts in therapy-naïve HIV-mono-infected and HIV/HCV-co-infected Chinese. PLoS One 2014;9:e96792. [PMID: 24816922 DOI: 10.1371/journal.pone.0096792] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
26 Muriuki BM, Gicheru MM, Wachira D, Nyamache AK, Khamadi SA. Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya. BMC Res Notes 2013;6:363. [PMID: 24016453 DOI: 10.1186/1756-0500-6-363] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
27 Du G, Li X, Musa TH, Ji Y, Wu B, He Y, Ni Q, Su L, Li W, Ge Y. The nationwide distribution and trends of hepatitis C virus genotypes in mainland China. J Med Virol 2019;91:401-10. [PMID: 30192393 DOI: 10.1002/jmv.25311] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
28 Yen YF, Yen MY, Su LW, Li LH, Chuang P, Jiang XR, Deng CY. Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan. BMC Public Health 2012;12:1066. [PMID: 23227904 DOI: 10.1186/1471-2458-12-1066] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
29 Chan DP, Lee SS, Lee KC. The effects of widespread methadone treatment on the molecular epidemiology of hepatitis C virus infection among injection drug users in Hong Kong. J Med Virol. 2011;83:1187-1194. [PMID: 21567422 DOI: 10.1002/jmv.22099] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
30 Thomas DL, Leoutsakas D, Zabransky T, Kumar MS. Hepatitis C in HIV-infected individuals: cure and control, right now. J Int AIDS Soc 2011;14:22. [PMID: 21548988 DOI: 10.1186/1758-2652-14-22] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
31 Zhang Z, Yao Y, Wu W, Feng R, Wu Z, Cun W, Dong S. Hepatitis C virus genotype diversity among intravenous drug users in Yunnan Province, Southwestern China. PLoS One. 2013;8:e82598. [PMID: 24358211 DOI: 10.1371/journal.pone.0082598] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
32 Fu Y, Qin W, Cao H, Xu R, Tan Y, Lu T, Wang H, Tong W, Rong X, Li G. HCV 6a prevalence in Guangdong province had the origin from Vietnam and recent dissemination to other regions of China: phylogeographic analyses. PLoS One. 2012;7:e28006. [PMID: 22253686 DOI: 10.1371/journal.pone.0028006] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 5.0] [Reference Citation Analysis]
33 Bao YP, Liu ZM, Lu L. Review of HIV and HCV infection among drug users in China. Curr Opin Psychiatry 2010;23:187-94. [PMID: 20308901 DOI: 10.1097/YCO.0b013e328338658b] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
34 Li Q, Yao Y, Shen Y, Cao D, Li Y, Zhang S, Cun W, Sun M, Yu J, Shi L. Assessment of HCV genotypes in Yunnan Province of Southwest China. Virus Genes. 2017;53:190-196. [PMID: 28012010 DOI: 10.1007/s11262-016-1420-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
35 Ju W, Yang S, Feng S, Wang Q, Liu S, Xing H, Xie W, Zhu L, Cheng J. Hepatitis C virus genotype and subtype distribution in Chinese chronic hepatitis C patients: nationwide spread of HCV genotypes 3 and 6. Virol J 2015;12:109. [PMID: 26206422 DOI: 10.1186/s12985-015-0341-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
36 Chen W, Liao B, Hu F, Nie J, Lan Y, Li H, Lu R, Gao Y, Song Y, Zhao Q, Zheng Y, Tang X, Cai W. Changing Epidemiology of Hepatitis C Virus Genotype among Patients with Human Immunodeficiency Virus/Hepatitis C Virus Co-Infection in China. PLoS One 2016;11:e0161844. [PMID: 27603929 DOI: 10.1371/journal.pone.0161844] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
37 Behzadpour D, Ahmadi Vasmehjani A, Mousavi Nasab SD, Ahmadi NA, Baharlou R. Impact of HIV infection in patients infected with chronic HCV (genotypes 1a and 3a): virological and clinical changes. Pathog Glob Health 2016;110:310-5. [PMID: 27830997 DOI: 10.1080/20477724.2016.1253532] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
38 Antaki N, Craxi A, Kamal S, Moucari R, Van der Merwe S, Haffar S, Gadano A, Zein N, Lai CL, Pawlotsky JM. The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report. Liver Int. 2010;30:342-355. [PMID: 20015149 DOI: 10.1111/j.1478-3231.2009.02188.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 109] [Article Influence: 8.8] [Reference Citation Analysis]
39 Zhou YB, Liang S, Wang QX, Gong YH, Nie SJ, Nan L, Yang AH, Liao Q, Song XX, Jiang QW. The geographic distribution patterns of HIV-, HCV- and co-infections among drug users in a national methadone maintenance treatment program in Southwest China. BMC Infect Dis 2014;14:134. [PMID: 24612875 DOI: 10.1186/1471-2334-14-134] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
40 Fu Y, Wang Y, Xia W, Pybus OG, Qin W, Lu L, Nelson K. New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors. J Viral Hepat 2011;18:42-52. [PMID: 20196805 DOI: 10.1111/j.1365-2893.2010.01280.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
41 Peng J, Lu Y, Liu W, Zhu Y, Yan X, Xu J, Wang X, Wang Y, Liu W, Sun Z. Genotype Distribution and Molecular Epidemiology of Hepatitis C Virus in Hubei, Central China. PLoS One 2015;10:e0137059. [PMID: 26325070 DOI: 10.1371/journal.pone.0137059] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
42 Zhuang X, Liang Y, Chow EP, Wang Y, Wilson DP, Zhang L. HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis. BMC Infect Dis 2012;12:130. [PMID: 22682091 DOI: 10.1186/1471-2334-12-130] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
43 Zhang L, Chow EP, Zhuang X, Liang Y, Wang Y, Tang C, Ling L, Tucker JD, Wilson DP. Methadone maintenance treatment participant retention and behavioural effectiveness in China: a systematic review and meta-analysis. PLoS One 2013;8:e68906. [PMID: 23922668 DOI: 10.1371/journal.pone.0068906] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 4.6] [Reference Citation Analysis]
44 Chou YC, Shih SF, Tsai WD, Li CS, Xu K, Lee TS. Improvement of quality of life in methadone treatment patients in northern Taiwan: a follow-up study. BMC Psychiatry 2013;13:190. [PMID: 23865898 DOI: 10.1186/1471-244X-13-190] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]